Literature DB >> 28042025

Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.

Emily B Askew1, Suxia Bai1, Amanda B Parris1, John T Minges1, Elizabeth M Wilson2.   

Abstract

Androgen receptor (AR) transcriptional activity depends on interactions between the AR NH2-terminal region and transcriptional coregulators. A yeast two-hybrid screen of a human testis library using predicted α-helical NH2-terminal fragment AR-(370-420) as bait identified suppressor of variegation 3-9 homolog 2 (SUV39H2) histone methyltransferase as an AR interacting protein. SUV39H2 interaction with AR and the AR coregulator, melanoma antigen-A11 (MAGE-A11), was verified in two-hybrid, in vitro glutathione S-transferase affinity matrix and coimmunoprecipitation assays. Fluorescent immunocytochemistry colocalized SUV39H2 and AR in the cytoplasm without androgen, in the nucleus with androgen, and with MAGE-A11 in the nucleus independent of androgen. Chromatin immunoprecipitation using antibodies raised against SUV39H2 demonstrated androgen-dependent recruitment of AR and SUV39H2 to the androgen-responsive upstream enhancer of the prostate-specific antigen gene. SUV39H2 functioned cooperatively with MAGE-A11 to increase androgen-dependent AR transcriptional activity. SUV39H2 histone methyltransferase is an AR coactivator that increases androgen-dependent transcriptional activity through interactions with AR and MAGE-A11.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Androgen receptor; Histone methyltransferase; MAGE-A11; Melanoma antigen-A11; SUV39H2

Mesh:

Substances:

Year:  2016        PMID: 28042025      PMCID: PMC5303141          DOI: 10.1016/j.mce.2016.12.028

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  78 in total

1.  A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.

Authors:  Slimane Ait-Si-Ali; Valentina Guasconi; Lauriane Fritsch; Hakima Yahi; Redha Sekhri; Irina Naguibneva; Philippe Robin; Florence Cabon; Anna Polesskaya; Annick Harel-Bellan
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

2.  Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.

Authors:  Emily B Askew; Suxia Bai; Amanda J Blackwelder; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

3.  Evolution of the primate androgen receptor: a structural basis for disease.

Authors:  C S Choong; J A Kemppainen; E M Wilson
Journal:  J Mol Evol       Date:  1998-09       Impact factor: 2.395

4.  Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.

Authors:  Shifeng Su; John T Minges; Gail Grossman; Amanda J Blackwelder; James L Mohler; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

5.  Expression of recombinant androgen receptor in cultured mammalian cells.

Authors:  V E Quarmby; J A Kemppainen; M Sar; D B Lubahn; F S French; E M Wilson
Journal:  Mol Endocrinol       Date:  1990-09

6.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

7.  Expression of MAGE genes in primary and metastatic cutaneous melanoma.

Authors:  F Brasseur; D Rimoldi; D Liénard; B Lethé; S Carrel; F Arienti; L Suter; R Vanwijck; A Bourlond; Y Humblet
Journal:  Int J Cancer       Date:  1995-11-03       Impact factor: 7.396

8.  An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP).

Authors:  Bin He; Suxia Bai; Andrew T Hnat; Rebecca I Kalman; John T Minges; Cam Patterson; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2004-04-23       Impact factor: 5.157

9.  Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.

Authors:  Liliana A Ponguta; Christopher W Gregory; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

10.  Structural biology of human H3K9 methyltransferases.

Authors:  Hong Wu; Jinrong Min; Vladimir V Lunin; Tatiana Antoshenko; Ludmila Dombrovski; Hong Zeng; Abdellah Allali-Hassani; Valérie Campagna-Slater; Masoud Vedadi; Cheryl H Arrowsmith; Alexander N Plotnikov; Matthieu Schapira
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more
  7 in total

Review 1.  Epigenetic Regulation in Prostate Cancer Progression.

Authors:  Katia Ruggero; Sonia Farran-Matas; Adrian Martinez-Tebar; Alvaro Aytes
Journal:  Curr Mol Biol Rep       Date:  2018-04-18

Review 2.  The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.

Authors:  Baihui Li; Yu Zheng; Lili Yang
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

3.  MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma.

Authors:  Shiheng Jia; Minghui Zhang; Yanshu Li; Lan Zhang; Wei Dai
Journal:  Cancer Manag Res       Date:  2020-02-26       Impact factor: 3.989

Review 4.  Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer.

Authors:  Tanggang Deng; Yugang Xiao; Yi Dai; Lin Xie; Xiong Li
Journal:  Front Mol Biosci       Date:  2021-12-15

Review 5.  Epigenetic and Epitranscriptomic Control in Prostate Cancer.

Authors:  Judith López; Ana M Añazco-Guenkova; Óscar Monteagudo-García; Sandra Blanco
Journal:  Genes (Basel)       Date:  2022-02-18       Impact factor: 4.096

Review 6.  Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer.

Authors:  Yifeng Mao; Gaowei Yang; Yingbang Li; Guowu Liang; Wangwang Xu; Mingqiu Hu
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

Review 7.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.